Today: 28 January 2026
Subscribe
Browse Category

NASDAQ:CAI News 30 December 2025 - 12 January 2026

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

NEW YORK, Jan 12, 2026, 15:29 (EST) — Trading in the regular session. Caris Life Sciences shares dropped roughly 8.5% to $26.08 in afternoon trading, after fluctuating between $25.35 and $29.77 earlier today. The update comes amid J.P. Morgan Healthcare Conference week, a time when healthcare firms typically try to recalibrate expectations ahead of earnings season. Investors are focused on…
12 January 2026
····
Why Caris Life Sciences (CAI) stock is down today as biotech slips

Why Caris Life Sciences (CAI) stock is down today as biotech slips

NEW YORK, December 30, 2025, 14:58 ET — Regular session Caris Life Sciences shares were down about 1.8% at $27.44 as of 2:41 p.m. ET, after trading between $27.00 and $27.97 during Tuesday’s session. The drop came as biotech stocks underperformed, with the SPDR S&P Biotech ETF down about 1.5% and the iShares Nasdaq Biotechnology ETF off about 1.2%. The…
30 December 2025
···

Stock Market Today

  • Gold Prices Soar to Record $5,300 as US Dollar Slides on Trump Comments
    January 28, 2026, 4:42 AM EST. Gold prices hit a record high of over $5,290 per troy ounce on Wednesday, driven by a near four-year low in the US dollar. The dollar index fell 0.2% to 96.08 following President Donald Trump's remarks suggesting comfort with a weaker currency. Analysts say Trump's stance signals a strategic risk, potentially benefiting US exporters and reducing the trade deficit. The dollar's slide undermines its usual role as a safe haven, prompting caution among investors. Geopolitical tensions and an upcoming Federal Reserve policy decision also added support to gold's rally.
Go toTop